FDA Inspection
Bayer AGBayer AG – FDA Inspection, Jan 20, 2017
Record Details
This FDA Inspection record concerns Bayer AG, with an inspection on January 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c65a5db9-942c-4b9b-a5cf-90ff21e2bf78
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1004195
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bayer AG
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 7, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bayer AG
- FDA Inspection 1247034 - 2023-09-07
- FDA Inspection 1209999 - 2022-05-13
- FDA Inspection 1125538 - 2020-07-27
- FDA Inspection 1084360 - 2019-03-22
- FDA Inspection 975815 - 2016-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.